Agreement - June 28, 2015
Sobi Dismisses Takeover Talk
Sobi’s board of directors has ended any discussions about the possible sale of all shares issued by the company. “Sobi will continue to focus on preparations for the upcoming planned launch of Elocta and Alprolix and on building value through its diverse and growing portfolio,” the company said in a statement. Sobi had a market value […]